The latter suggests that nTreg and aTreg comprise phenotypically suppressive FOXP3+ cells in our patients with CLL, as Treg-suppressive function is linked to both low expression of CD127 and high surface expression levels of CD25 [45,46]. Here, FOXP3 is linked to B-cell chronic lymphocytic leukemia.